Down syndrome (DS), as a phenotypic result of trisomy 21, is the most frequent aneuploidy at birth and the most common known genetic cause of mental retardation. DS is also characterized by other phenotypes affecting many organs, including brain, muscle, heart, limbs, gastrointestinal tract, skeleton, and blood. Any of the human chromosome 21 (Hsa21) genes may contribute to some of the DS phenotypes. To determine which of the Hsa21 genes are involved in DS, the effects of disrupting and overexpressing individual human gene orthologs in model organisms, such as the nematode Caenorhabditis elegans, can be analyzed. Here, we isolated and characterized C21orf80 (human chromosome 21 open reading frame 80), a potential novel protein O-fucosyltransferase gene that encodes three alternatively spliced transcripts. Transient expression of tagged C21orf80 proteins suggests a primary intracellular localization in the Golgi apparatus. To gain insight into the biological role of C21orf80 and its potential role in DS, we isolated its C. elegans ortholog, pad-2, and performed RNA interference (RNAi) and overexpression experiments. pad-2(RNAi) embryos showed failure to undergo normal morphogenesis. Transgenic worms with elevated dosage of pad-2 displayed severe body malformations and abnormal neuronal development. These results show that pad-2 is required for normal development and suggest potential roles for C21orf80 in the pathogenesis of DS. D
Down syndrome (DS), caused by trisomy 21, is the most common genetic cause of mental retardation, with an incidence of approximately 1 in 700 live births. DS patients show several clinical manifestations that affect multiple organs with variable penetrance. In addition to mental retardation and facial characteristics, there are numerous other phenotypes associated with DS, including heart disease and early onset Alzheimer disease [3] . The completion of the genomic sequence of human chromosome 21 (Hsa21) [12] and its mouse syntenic regions [23, 31] is facilitating the discovery of the Hsa21 genes [2, 7, 26, 27] . After the charac-terization of the Hsa21 gene repertoire, the next issue is to uncover their functions and to determine which ones are involved in the phenotypes of DS [9, 28] . Model organisms will be essential to determine the function of these genes by studying the functional/phenotypical effects of their inactivation and overexpression. The nematode Caenorhabditis elegans is an attractive experimental model organism to study gene function. Despite its apparent rudimentary organization, the main cell types affected in DS, including muscle cells and neurons, can be individually identified [1, 30] . Importantly, approximately 25% of Hsa21 genes exhibit a high level of sequence homology to genes within the C. elegans genome [8] .
Here, we report the isolation and initial characterization of C21orf80, a potential new protein O-fucosyltransferase that maps to Hsa21. Protein O-fucosyltransferase is an emerging class of enzymes that add O-fucose to conserved serine or threonine residues in the epidermal growth factorlike domains of a number of cell surface and secreted proteins. Recent studies have shown that signaling events involved in development can be regulated by O-fucosylation [11] . To determine the biological role of C21orf80 in development and its potential involvement in DS, its C. elegans ortholog pad-2 was isolated and characterized. Both disruption and overexpression of pad-2 revealed essential functions in normal development and suggested possible roles for C21orf80 in the pathogenesis of DS.
Results

Isolation of the human C21orf80 gene and its C. elegans ortholog
In silico analysis of approximately 1 Mb of 21q22.3 genomic sequence revealed the existence of a new gene, subsequently named C21orf80. The C21orf80 gene is composed of 10 exons and spans over 24 kb of genomic sequence between ADARB1 and COL18A1. We identified three different alternatively spliced transcripts. C21orf80a (AJ302080) is a 424-amino-acid putative protein. This isoform results from introns 8 and 9 not being spliced. C21orf80b (AJ302079) contains all the exons, is 3055 bp in size, and encodes a putative 380-amino-acid protein. C21orf80c (AY066015) results from the splicing out of exon 9, is 2849 bp in size, and encodes a putative 429-amino-acid protein (Fig. 1A) . Homology searches against publicly available databases revealed that C21orf80 is also known as POFUT2 (FUT13; AJ575591), a member of a newly identified protein O-fucosyltransferase family, POFUT2 [20] .
The human C21orf80b protein sequence was used to search the mouse, Drosophila, and C. elegans genome databases. A unique C. elegans ortholog of C21orf80 (Z36282, ORF K10G9.3) was identified and confirmed by RT-PCR. It is composed of five exons, spans approximately 2 kb of genomic sequence, and encodes a putative protein of 426 amino acids that shows 45% identity to the human C21orf80b protein (Fig. 1B) . No alternative transcripts were identified in C. elegans. The C. elegans ortholog of C21orf80 was named pad-2, which stands for C. elegans patterning defective-2 (see later in the text [10] ). The mouse C21orf80 ortholog (AF455270) encodes a protein of 429 amino acids and shows 92% identity with the human C21orf80b protein. The Drosophila ortholog O-fucosyltransferase 2 (AAF45629) encodes a 490-amino-acid protein that shows 38% identity with the human C21orf80b protein. Two different mRNA species of 3.0 and 2.3 kb were detected. Northern blot analysis was performed using a probe designed to detect all three C21orf80 mRNA isoforms. (B) Multiple sequence alignment of the deduced amino acid sequence of the human C21orf80b (AJ302079), the mouse C21orf80 ortholog (AF455270), the C. elegans C21orf80 ortholog (AF455271), and the Drosophila ortholog O-fucosyltransferase 2 CG14789-PA (AAF45629). The mouse C21orf80 cDNA was isolated by assembling ESTs (BG915839, BI646651, AI550762). Identical amino acids are shaded in black. Conserved amino acids are shaded in gray.
Expression pattern and intracellular localization of C21orf80
Northern blot analysis revealed a ubiquitous band of approximately 3 kb that could correspond to C21orf80b and/or c. A faint 2.5-kb band was also observed in brain (Fig. 1A) . RT-PCR was performed on a panel consisting of 24 human cDNA samples [28] to determine the expression profile of each of the three C21orf80 transcripts. C21orf80a was found to be expressed in fetal liver and peripheral blood lymphocytes. C21orf80b was detected in spleen, lung, testis, bone marrow, fetal brain, fetal liver, fetal kidney, thymus, pancreas, and prostate. C21orf80c was detected in brain, heart, spleen, liver, lung, stomach, testis, placenta, skin, fetal brain, fetal liver, fetal heart, thymus, pancreas, mammary gland, and prostate (data not shown).
To determine where C21orf80 might exert its cellular function, EGFP-C21orf80 or HA -C21orf80 proteins were expressed in COS-7 and U2OS cells. In both cell types, C21orf80 proteins were found in the cytoplasm chiefly in one or more perinuclear spots (Fig. 2) . To define better the compartments identified by C21orf80 proteins, colocalization experiments were performed in COS-7 cells using markers specific for the Golgi apparatus, the endoplasmic reticulum, and the microtubule network. The results showed that C21orf80 proteins colocalize to some extent with Giantin, a Golgi apparatus-specific protein (Fig. 2 , data not shown for C21orf80a and c).
pad-2(RNAi) embryos show patterning defects
We used RNA-mediated interference (RNAi) to investigate the role of pad-2, the C. elegans ortholog of C21orf80, in development. pad-2, previously described as a predicted gene (K10G9.3), had not been considered a genuine ORF and thereby avoided large-scale RNAi screening. Feeding worms with bacteria expressing pad-2 double-stranded RNA (dsRNA) caused embryonic lethality at an average penetrance of 17% ( Table 1 ). The affected pad-2(RNAi) embryos arrested growth and development at various stages, beginning at the onset of morphogenesis, when terminal differentiation occurs [15, 30] . They also displayed obvious body malformations owing to the failure in embryonic patterning and elongation (Figs. 3B, 3D , 3G, and 3K). The presence of autofluorescent gut granules (Fig. 3B) as well as the expression of the epidermal marker jam-1Dgfp (Fig. 3H) , the neuron-specific unc119Dgfp (Fig. 3L) , and the body wall muscle reporter myo-3Dgfp (data not shown) suggested that at least some cell types were properly differentiated in pad-2(RNAi) embryos [6, 18, 22] . However, the gut granules were mislocalized at the periphery of the arrested embryos (Figs. 3A and 3B), the epidermal cells were tightly clustered and displayed abnormal size and shape (Figs. 3F and 3H), and the prospective ventral nerve cord was either absent or mislocalized in 10% of the pad-2(RNAi) embryos (Figs. 3J and 3L ). The body wall muscle marker myo-3Dgfp also indicated, although with a moderate penetrance, cell patterning defects. These data demonstrate that pad-2 is required for embryonic morphogenesis by controlling body elongation and positioning of several cell types, including intestinal, hypodermal, body wall muscle, and neuronal cells.
Inactivation of pad-2 by RNAi disrupts cellular integrity and decreases fertility pad-2 dsRNA treatment caused a highly variable and incomplete penetrant phenotype during postembryonic development. Approximately f2% of pad-2(RNAi) animals arrested development at different larval stages or at young adulthood, exhibiting severe body malformations (data not shown). The viable pad-2(RNAi) larvae and adults were characterized by loss or significant reduction of UNC-119DGFP staining in the ventral nerve cord neurons ( Fig.  4B ) and in other neuronal cells (not shown). Upon differential interference contrast microscopy, the majority of these neurons did not show signs of degeneration during development but rather an irregular size and position. The integrity of the axonal bundles also appeared to be disrupted. Furthermore, using the myo-3Dgfp marker highlighting myosin heavy chain A, structural changes in the body wall muscle cells of pad-2(RNAi) worms were observed. In wild-type animals, the muscle cell sarcomeres were organized in tight parallel symmetric rows (Fig. 4C) . In pad-2(RNAi) worms the sarcomeres became disorganized with marked signs of irregular orientation (Fig. 4D ). Changes in neuronal or muscle cell structure, or both, can explain the egg-laying-defective (Egl) phenotype (<5%) observed in pad-2(RNAi) hermaphrodites (not shown). Occasionally, pad-2(RNAi) hermaphrodites displayed obvious defects in vulval development owing to abnormal orientation of vulval cell division (data not shown), which might have contributed to the observed Egl and/or everted vulva phenotypes.
The fertility of pad-2(RNAi) hermaphrodites was highly reduced. We found a mean ''brood size'' (all laid eggs) of 96 F 16.5 in pad-2(RNAi) adults versus 191 F 14.5 in wildtype animals. A portion of the oocytes produced by the RNAi-treated animals remained unfertilized after passing through the spermatheca (Fig. 4F ). Although the spermatozoids looked normal, their number was significantly lower in 7 of 10 pad-2(RNAi) hermaphrodites (85 -135 spermatozoids/spermatheca in pad-2(RNAi) hermaphrodites in contrast to 170 -195 in wild-type animals, n = 10). A similar phenomenon was observed in pad-2(RNAi) males (data not shown), indicating that pad-2 affects spermatozoid differentiation in both sexes.
Overexpression of pad-2 affects morphogenesis
In an effort to dissect the potential implication of three copies of C21orf80 in DS, we have evaluated the effect of an increased dose of pad-2 on C. elegans development. Overexpression of pad-2 from a heat-inducible promoter cells are sensitive to excessive and/or ectopic pad-2 dosage. that is active in almost all somatic cells [5] caused a highly
The developmental stage at which the affected embryos penetrant embryonic lethality (83%, Table 2 ) accompanied arrested growth varied highly among individuals. To restrict by severe body malformations, indicating that embryonic the overexpression of pad-2 to the appropriate tissues and to Table 2 ) and early larval arrest characterized by mild to severe morphogenetic abnormalities (Figs. 5A , 5B, 5D, and 5E). Although the K10G9-transgenic arrested animals exhibited almost normal body elongation and tissue differentiation, they showed obvious patterning defects that were manifested in severe body malformations mainly in the head and tail as well as in protrusions along the entire anteroposterior body axis. Levels of transgene expression were estimated by semiquantitative PCR that showed increased dose of pad-2 mRNA in both transgenic strains (hsDpad-2 and cosmid K10G9) compared to wild-type animals (Fig. 5F ). It must be noted that we could not formally exclude the possible effect of K10G9.2, the only other full-length gene present in cosmid K10G9, on the observed phenotype. However, overexpressing pad-2 under a heat shock promoter or its own promoter resulted in the same phenotype characterized by embryonic lethality associated with various morphological defects. Furthermore, consistent with the level of pad-2 overexpression, the penetrance of this phenotype was much higher when pad-2 was overexpressed under a heat shock promoter. Taken together, our experimental results indicate that embryonic lethality in animals transgenic for cosmid K10G9 was caused by extra copies of pad-2.
To evaluate the effects of elevated pad-2 dose on cell fate determination, we examined the expression of the neuronal marker unc-119Dgfp in animals transgenic for K10G9. Interestingly, we detected a more intense and ectopic UNC-119DGFP accumulation in the K10G9 transgenic embryos compared with the wild-type expression pattern (Figs. 5G -5N ). For example, the border of the UNC-119DGFP-positive area in the head was slightly shifted toward the posterior pole. Furthermore, certain neurons, for example those that belong to the ventral nerve cord, expressed UNC-119DGFP at abnormally high levels. This observation is consistent with the characterization of the pad-2 RNAi phenotype, which revealed a faint and reduced UNC-119DGFP expression relative to that found in the wild type. These data suggest that pad-2 influences cell identity at least in neurons in a dosage dependent manner.
pad-2 is expressed in different cell types from morphogenetic embryonic stages throughout development
The expression pattern of pad-2 was analyzed by using animals carrying a pad-2Dgfp reporter, swEx571, tagged with a nuclear localization signal. Consistent with the observed pad-2 RNAi phenotypes, pad-2 expression starts during the morphogenetic period of embryonic development. At this stage it was detectable in the anterior part of the embryos, in the hypodermal and neuronal cells of the head (Fig. 6A) . After the animal hatched, pad-2 was expressed at different levels in a variety of cell types, including neuronal, hypodermal, muscle, intestinal, and somatic gonadal cells (Fig. 6C and data not shown) . PAD-2DGFP accumulation was most intense in the nerve ring around the pharynx (Fig. 7A) , in the dorsal and ventral nerve cords (Fig. 7B) , in the intestine, and in a variety of hypodermal cells (Fig. 7C) of the L1 -L3-stage larvae. In Fig. 4 . pad-2 RNAi affects the integrity of neuronal and body wall muscle cells and reduces fertility. (A) Ventral nerve cord (arrow) in a wild-type L4-stage larva expressing the neuronal marker UNC-119DGFP. (B) Many of the ventral cord neurons failed to express UNC-119DGFP in a pad-2(RNAi) L4 larva. The integrity of the axonal bundles is also disrupted (arrow). (C and D) Fluorescence micrographs showing a body wall muscle cell from a wild-type and a pad-2(RNAi) L4 larva, respectively. Both animals are transgenic for the body wall muscle marker myo-3Dgfp. Sarcomeres are organized in tight symmetric parallel rows in the wild-type animal, whereas they reflect irregular orientation in the pad-2 RNAi-treated animal. (E and F) DIC images of wild-type and pad-2(RNAi) hermaphrodites, respectively. The white-filled arrow shows the vulva, the black arrow points to the spermatheca. As the oocytes pass through the spermatheca, they start to divide in the wild-type animals but remain unfertilized in the pad-2(RNAi) animals. Bars represent 20 Am in A, B, E, and F and 10 Am in C and D. adult hermaphrodites, gonadal sheath cells, spermatheca, and tissues surrounding the vulva showed intense pad-2 expression (Fig. 7D ). These observations are consistent with sterility and vulva-specific phenotypes found in pad-2(RNAi) hermaphrodites. PAD-2DGFP was also expressed in the body wall muscle and hypodermal cells in both sexes (Figs. 7F and 7G).
Discussion
Down syndrome is a complex disorder caused by trisomy of Hsa21. The current hypothesis for how trisomy 21 leads to DS is that some genes, but not all, contribute to aspects of the DS phenotype. Clarifying the roles of individual Hsa21 genes in DS requires both overexpression and knockout approaches in model organisms. Here, we describe the isolation and initial characterization of C21orf80, a potential new protein O-fucosyltransferase. C21orf80 is ubiquitously expressed in human tissues and may primarily localize in the Golgi apparatus, two characteristics of many other glycosyltransferases [14] . High level of homology among human, mouse, Drosophila, and C. elegans C21orf80 proteins indicates an evolutionarily conserved biological role. Recent studies have provided evidence of a role for O-fucosylation in signal pathways involved in development [11] . The most remarkable example is the demonstration that O-fucose modification by protein O-fucosyltransferase (OFUT1) is essential for most, and possibly all, aspects of Notch signaling [24, 25] . Based on these results, we hypothesize that overexpression of C21orf80 in DS could lead to variation in the profile of O-fucosylation on target proteins, influencing their function by eliciting a new conformational change or masking or creating new recognition sites between proteins.
To investigate the biological role of C21orf80 and its potential involvement in DS, we isolated its C. elegans ortholog, pad-2. Downregulation of pad-2 resulted in a pleiotropic phenotype observed at different stages of development. Consistent with the onset of pad-2 expression during the morphogenetic period of embryonic development, affected pad-2(RNAi) embryos failed to undergo normal morphogenesis and showed arrested development. A more detailed analysis of the embryonic phenotype revealed abnormal positioning of several cell types without apparently affecting tissue differentiation. For example, the prospective ventral nerve cord, the intestine, the hypodermis, and the body wall muscle cells were mislocalized or partially formed in a fraction of pad-2(RNAi) embryos.
Most of the tissues expressing pad-2 at the larval and adult stages were affected upon RNAi, although the penetrance of postembryonic phenotypes was highly incomplete. pad-2(RNAi) adult hermaphrodites displayed abnormal vulval development and reduced fertility, consistent with strong pad-2 expression in developing vulval tissue of L3 and L4 stage larvae and in the gonadal sheath cells and spermatheca of adult hermaphrodites. These observations suggest that pad-2 is involved in vulval cell fate specification as well as germ cell generation. pad-2(RNAi) larvae also showed obvious cell fate specification defects in certain neurons, especially in the ventral nerve cord, consistent with strong expression of pad-2 in these cells. This suggests a role for pad-2 in neuronal development and survival. pad-2 is also required for the integrity of body wall muscle cells by controlling the orientation of sarcomeres. Even observed at incomplete penetrance, these phenotypes were considered significant as they were reproducible and never observed in wild-type animals.
Overexpression of pad-2 under the control of a heat shock promoter that is active in most somatic cells resulted in highly penetrant embryonic lethality, indicating that the correct dose of pad-2 is critical for normal development. However, strong overexpression of many genes in a nonphysiological manner will almost certainly result in an apparent phenotype [19, 32] . Therefore, transgenic worms were generated with the cosmid K10G9, which contains pad-2 and its endogenous regulatory sequences. K10G9 transgenic animals also showed embryonic lethality and morphogenetic defects. Our findings suggest that a correct dosage of pad-2 is necessary for normal development.
C. elegans neuronal development was affected in both pad-2(RNAi) and K10G9 transgenic embryos. Notably, pad-2 downregulation or overexpression caused disorganization of the developing neuronal network in the opposite manner. Absence of pad-2 resulted mostly in the loss or reduced expression of a neuronal marker, whereas pad-2 overexpression seemed to activate neuronal proliferation and/or specification. This implies that pad-2 may act as a coordinator of cell fate specification and tissue patterning during embryonic neural development.
Interestingly, the gene defective in leukocyte adhesion deficiency II (LADII) encodes a putative GDP-fucose transporter [16, 17] . The fucosylation of glycoproteins was found to be defective in individuals with LADII who suffer from severe infections, persistent leukocytosis, short stature, unusual facial and skeletal abnormalities, and severe mental retardation pointing to the importance of fucosylation for the development of the neuronal system.
Taken together, these results suggest a potential role for C21orf80 in DS phenotypes.
Materials and methods
Isolation of the human C21orf80 cDNA and gene
Detailed analysis of 21q22.3 genomic DNA (GenBank Nos. AL163300, AL163301, and AL163302) was performed using numerous computer programs, interfaced by NIX (http://www.hgmp.mrc.ac.uk/NIX/), a program that integrates most of the gene identification programs. Subsequently, 5V-and 3V-RACE and RT-PCR reactions were performed on human brain, placenta, and liver cDNAs using primers designed within predicted exons of a novel gene named C21orf80. The sequence of the primers used is available at http://www.medgen.unige.ch. The genomic structure and intron -exon junctions of C21orf80 were determined by comparison of the genomic sequence with the cDNA sequences by using est _ genome software (http:// www.hgmp.mrc.ac.uk). C21orf80 protein sequences were analyzed using the Tools and software packages at the Expasy Molecular Biology Server (http://au.expasy.org/).
Expression pattern of C21orf80
Northern blot analysis was performed on a commercially available blot (Origene Technologies, Rockville, MD, USA) containing 2 Ag of poly(A) + RNA from six adult tissues according to the manufacturer's recommendations. A partial cDNA clone spanning exons 4 to 9 of the C21orf80b transcript was used as a probe. The absence of C21orf80 transcript in spleen is likely to be due to the very low quantity of spleen mRNA blotted on the membrane as shown by the weak signal obtained with the h-actin control probe. RT-PCR was performed on a panel consisting of 24 human cDNA samples prepared as described [28] . The sequences of the primers used in this analysis are available on our Web page: http://www.medgen.unige.ch/.
Intracellular localization of C21orf80 proteins
To visualize the intracellular localization of the C21orf80 proteins, COS-7 and U2OS cells were transiently transfected with vectors expressing either 5VEGFP-or 5VHA-tagged C21orf80 proteins as previously described [29] . To perform colocalization with known subcellular compartments, transfected COS-7 and U2OS cells were incubated with antibodies recognizing specific cellular structures: Golgi by a mouse antiGiantin antibody (Calbiochem, San Diego, CA, USA); anti-a, -h, and -y tubulin antibodies (Sigma-Aldrich, Munich, Germany), and the dye Endoplasmic Reticulum-Tracker BlueWhite DPX (Molecular Probes, Eugene, OR, USA).
Isolation of pad-2 cDNA, the C. elegans ortholog of C21orf80
The C. elegans ortholog of the human C21orf80 gene was identified by tBLASTn using the human protein sequence against the C. elegans genomic DNA sequence. The full-length coding sequence of pad-2 was isolated by RT-PCR using C. elegans poly(A) + RNA. The genomic structure and intron -exon junctions of pad-2 were determined by comparison of the genomic sequence with the cDNA sequence by using est _ genome software (http:// www.hgmp.mrc.ac.uk). The sequence of the primers used is available at http://www.medgen.unige.ch.
C. elegans strains, alleles, and general methods C. elegans strains were maintained using standard methods [1] . Wild-type worms correspond to C. elegans var. Bristol, strain N2. Other strains were FR709 swEx573[hsDpad-2 + rol-6(su1006)]; FR710 swEx574[hsDpad-2 + rol-6(su1006)]; DP132 edIs[unc-119Dgfp + rol-6(su1006)]IV; FR711 swEx575[K10G9 + rol-6(su1006)]; FR706 swEx571[pad2Dgfp + ro-6(su1006)]; FR707 swEx572[pad-2Dgfp + ro-6(su1006)]; FR775 CcIs4251[myo-3Dgfp + dpy-20(+)]V, dpy-20(e1362)IV; su93 jcIs1[jam-1Dgfp + rol-6(su1006) + unc-29(+)]IV [22] ; and DP132 edIs[unc-119Dgfp + rol-6(su1006)]IV [18] . The unc-119Dgfp, myo-3Dgfp and jam-1Dgfp reporters were used as neuronal, muscle, and epidermal markers, respectively. The strain expressing the hsDpad-2/rol-6 array was maintained at 15jC, other strains were analyzed at 22jC.
RNAi assay
A 951-bp fragment of the pad-2 cDNA was amplified by RT-P C R u s i n g p r i m e r s 5 V-C C G C T C G A G C G -GACCGTGTCTCGGGTGGACTCGAAC-3V and 5V-[GGACTAGTCCAACAGAGCTTTGAGCTCATCGAC-3V and subcloned into pPD129.36 [6] . This construct, called pGEN1, was transformed into HT115(DE3) Escherichia coli strain. Bacteria containing pGEN1 were grown and induced as described [13] , then seeded directly onto nematode growing medium (NGM) plates with 1 mM IPTG and 50 Ag/ml ampicillin. To examine the effects of pad-2 RNAi, wild-type L4-stage larvae were transferred onto NGM plates seeded with bacteria that were expressing pad-2 dsRNA, and the F1 siblings were analyzed.
Overexpression of pad-2
The pad-2 cDNA was digested with restriction enzymes NheI/KpnI and cloned into pPD49.83, which contains the C. elegans hsp16-41 heat-inducible promoter [4] . This construct, called pGEN2 (hsDpad-2), was co-injected with pRF4 carrying the dominant transformation marker gene rol-6(su600) at 50 ng/Al concentration into young adult hermaphrodites as previously described [21] . Worm lines transgenic for the hsDpad-2/rol-6 array were established (strains FR709 and FR710) and heat shocked three or four times, each round being 33jC for 30 min followed by 20jC for 3 h and 30 min. The cosmid K10G9, which contains pad-2(K10G9.3) and its upstream regulatory sequences (http://www.wormbase.org), was also injected into young hermaphrodites, and a transgenic line (strain FR711) was established. To examine neuronal development in K10G9 transgenic animals, the strains FR711 and DP132 (unc119Dgfp) were crossed.
Analysis of pad-2 overexpression was performed by RT-PCR. Total RNA was isolated from 30 wild-type, hsDpad-2 transgenic, or K10G9 transgenic L4-stage larvae. pad-2 and ama-1 mRNAs were amplified by the Qiagen one-step RT-PCR system using primers 5V-AAATTCGAGAAACG-GAGCTG-3V and 5V-TACTCCTTCTCGCCTTCCAG-3V for pad-2, 5V-CAGTGGCTCATGTTCGAGT-3V and 5V-CGACCTTCTTTCCATCAT-3V for ama-1. PCR products were separated on agarose gel and transgene expression levels were estimated using the respective intensity of the ethidium bromide bands using the Multi-Analyst software (Bio-Rad).
Expression analysis of pad-2
A 5-kb genomic fragment containing the first three exons of pad-2 and 3 kb of upstream sequence (the closest upstream gene, R01H10.8, is located 2 kb from pad-2) was cloned into pPD95.69 (provided by A. Fire). This construct, called pGEN3, expresses the PAD-2DGFP fusion protein tagged with a nuclear localization signal under the control of the pad-2 endogenous promoter. pGEN3 was coinjected with pRF4 into wild-type hermaphrodites. Two transgenic lines (FR706 and FR707) were established and examined using a Leica DM RXA epifluorescence micro-scope equipped with DIC optics. Images were taken with a Hamamatsu chilled CCD camera (C5985) and processed with the Argus-20 Image Processor (Hamamatsu) using Adobe PhotoShop (4.0).
